Topic: HAE WITH NORMAL C1 INHIBITOR: HOW TO CORRECTLY DIAGNOSE AND TREAT THIS RARE TYPE OF RECURRENT ANGIOEDEMA
Date: April 4, 2024
Time: 4:00 to 5:00 pm CEST
Click HERE to register
Introduction and Moderation 5’
Thomas Buttgereit
Evolving recognition of HAE-nC1INH 15’
Anete S. Grumach
HAE-nC1INH – presentation of clinical cases 15’
Thomas Buttgereit
Estimated prevalence and treatment patterns
of HAE with normal C1 inhibitor – an US perspective 15’
Marc Riedl
Discussion and Q&A 10’
Moderated by Thomas Buttgereit
Read more news from ACARE
- February 23, 2023
In the hereditary disease hereditary angioedema (HAE), swellings occur in one or more parts of the body without a recognisable trigger. Especially if the upper respiratory tract is affected, a [...]
- October 13, 2023
Dr Thomas Buttgereit is joined by Dr Carolina Vera to discuss the use of attenuated androgens in the treatment of hereditary angioedema and their associated risks and side effects. Both [...]
- March 28, 2023
STATE OF THE ART MANAGEMENT OF RECURRENT ANGIOEDEMA AND HANDS ON TRAINING with special focus on Canada and Europe (applied for CME) Click here to register. The overall aim [...]
